Osteopontin as a marker in thyroid disease: Relation to body mass index

ABSTRACT: Background: Thyroid diseases are considered of the most common and important endocrinological disorders that are associated with multiple deleterious effects. Osteopontin (OPN), a molecule first identified in osteoblasts, is a multifunctional protein involved in inflammation, cell adhesio...

Full description

Bibliographic Details
Main Authors: Hanaa Tarek El-Zawawy, Aliaa Ali El-Aghoury, Eman Zaki Azzam, Akram Abdel Moneim Deghady, Marzouk Arafa Abdellatif
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Endocrine and Metabolic Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396120300030
_version_ 1831583459028500480
author Hanaa Tarek El-Zawawy
Aliaa Ali El-Aghoury
Eman Zaki Azzam
Akram Abdel Moneim Deghady
Marzouk Arafa Abdellatif
author_facet Hanaa Tarek El-Zawawy
Aliaa Ali El-Aghoury
Eman Zaki Azzam
Akram Abdel Moneim Deghady
Marzouk Arafa Abdellatif
author_sort Hanaa Tarek El-Zawawy
collection DOAJ
description ABSTRACT: Background: Thyroid diseases are considered of the most common and important endocrinological disorders that are associated with multiple deleterious effects. Osteopontin (OPN), a molecule first identified in osteoblasts, is a multifunctional protein involved in inflammation, cell adhesion &amp; remodeling. It has been suggested that OPN plays a role in many diseases. Aim of the work: To assess the alteration of serum OPN in patients with several forms of thyroid dysfunction and the relation of OPN to body mass index (BMI) in those patients. Patients and methods: Study subjects were recruited from the endocrine outpatient clinic in Alexandria Main University Hospital. They were divided into; Group I: 25 hyperthyroid patients, Group II: 25 hypothyroid patients, and Group III: 25 healthy euthyroid subjects as a control group. Results: OPN was significantly higher in hyperthyroid group than in control group (mean 11.07 ± 2.87 µg/l Vs mean 6.50 ± 1.71 µg/l, p<0.001) while, it was significantly lower in hypothyroid group than in control group (mean 4.07 ± 1.30 µg/l Vs mean 6.50 ± 1.71 µg/l, p<0.001). OPN showed a significant positive correlation with TRAbs and a significant negative correlation with BMI. Conclusion: Direct relationship existed between OPN and thyroid hormones. OPN was significantly negatively correlated with BMI in patients with hyperthyroidism; hence OPN can be suggested to act as a mediator of BMI change in hyperthyroid patients.
first_indexed 2024-12-17T20:42:33Z
format Article
id doaj.art-b418d7889d6845d9a3cb2656eecb0336
institution Directory Open Access Journal
issn 2666-3961
language English
last_indexed 2024-12-17T20:42:33Z
publishDate 2020-07-01
publisher Elsevier
record_format Article
series Endocrine and Metabolic Science
spelling doaj.art-b418d7889d6845d9a3cb2656eecb03362022-12-21T21:33:15ZengElsevierEndocrine and Metabolic Science2666-39612020-07-0111100049Osteopontin as a marker in thyroid disease: Relation to body mass indexHanaa Tarek El-Zawawy0Aliaa Ali El-Aghoury1Eman Zaki Azzam2Akram Abdel Moneim Deghady3Marzouk Arafa Abdellatif4Internal Medicine department, Endocrinology unit, Faculty of Medicine, Alexandria University, Egypt; Correspondig author:Internal Medicine department, Endocrinology unit, Faculty of Medicine, Alexandria University, EgyptInternal Medicine department, Endocrinology unit, Faculty of Medicine, Alexandria University, EgyptClinical pathology department, Faculty of Medicine, Alexandria University, EgyptInternal Medicine department, Endocrinology unit, Faculty of Medicine, Alexandria University, EgyptABSTRACT: Background: Thyroid diseases are considered of the most common and important endocrinological disorders that are associated with multiple deleterious effects. Osteopontin (OPN), a molecule first identified in osteoblasts, is a multifunctional protein involved in inflammation, cell adhesion &amp; remodeling. It has been suggested that OPN plays a role in many diseases. Aim of the work: To assess the alteration of serum OPN in patients with several forms of thyroid dysfunction and the relation of OPN to body mass index (BMI) in those patients. Patients and methods: Study subjects were recruited from the endocrine outpatient clinic in Alexandria Main University Hospital. They were divided into; Group I: 25 hyperthyroid patients, Group II: 25 hypothyroid patients, and Group III: 25 healthy euthyroid subjects as a control group. Results: OPN was significantly higher in hyperthyroid group than in control group (mean 11.07 ± 2.87 µg/l Vs mean 6.50 ± 1.71 µg/l, p<0.001) while, it was significantly lower in hypothyroid group than in control group (mean 4.07 ± 1.30 µg/l Vs mean 6.50 ± 1.71 µg/l, p<0.001). OPN showed a significant positive correlation with TRAbs and a significant negative correlation with BMI. Conclusion: Direct relationship existed between OPN and thyroid hormones. OPN was significantly negatively correlated with BMI in patients with hyperthyroidism; hence OPN can be suggested to act as a mediator of BMI change in hyperthyroid patients.http://www.sciencedirect.com/science/article/pii/S2666396120300030OsteopontinThyroidBMI
spellingShingle Hanaa Tarek El-Zawawy
Aliaa Ali El-Aghoury
Eman Zaki Azzam
Akram Abdel Moneim Deghady
Marzouk Arafa Abdellatif
Osteopontin as a marker in thyroid disease: Relation to body mass index
Endocrine and Metabolic Science
Osteopontin
Thyroid
BMI
title Osteopontin as a marker in thyroid disease: Relation to body mass index
title_full Osteopontin as a marker in thyroid disease: Relation to body mass index
title_fullStr Osteopontin as a marker in thyroid disease: Relation to body mass index
title_full_unstemmed Osteopontin as a marker in thyroid disease: Relation to body mass index
title_short Osteopontin as a marker in thyroid disease: Relation to body mass index
title_sort osteopontin as a marker in thyroid disease relation to body mass index
topic Osteopontin
Thyroid
BMI
url http://www.sciencedirect.com/science/article/pii/S2666396120300030
work_keys_str_mv AT hanaatarekelzawawy osteopontinasamarkerinthyroiddiseaserelationtobodymassindex
AT aliaaalielaghoury osteopontinasamarkerinthyroiddiseaserelationtobodymassindex
AT emanzakiazzam osteopontinasamarkerinthyroiddiseaserelationtobodymassindex
AT akramabdelmoneimdeghady osteopontinasamarkerinthyroiddiseaserelationtobodymassindex
AT marzoukarafaabdellatif osteopontinasamarkerinthyroiddiseaserelationtobodymassindex